Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream
Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.
Bleeding reversal agent pulled from market over FDA’s safety concerns
AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.
ACC calls for better management of peripheral artery disease in diabetic patients
PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.
Surgeons use modified ‘frozen elephant trunk’ technique for first heart surgery of its kind
When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.
New Medtronic thrombectomy system used commercially for first time
The new device uses an advanced algorithm to regulate aspiration and conserve blood. Ajit Rao, MD, a vascular surgeon with The Mount Sinai Hospital, performed the historic procedure.

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Intravascular lithotripsy tied to superior long-term PAD, PCI outcomes at SCAI 2022

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

Medical device company raises $23M for fully absorbable vessel closure patches

Vivasure Medical will use the funds to advance clinical development and attempt to secure regulatory approval of its vessel closure devices.

New bleeding stroke guidelines highlight several common treatments that may be ineffective

The updated document, developed by the American Heart Association and American Stroke Association, also emphasizes the potential benefits of caregiver training and MR imaging.

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis.

transcatheter aortic valve replacement (TAVR) procedure guided by CT fusion imaging on a patient with heart failure and a blood clot

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC.22

The new Shockwave Medical M5+ peripheral intravascular lithotripsy (IVL) catheter made its debut at ACC.22.

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1] However, the study’s authors noted, it did still lead to considerable improvements in stroke risk.

Carotid endarterectomy does not reduce long-term dementia risk

However, researchers noted, there was still a clear improvement in stroke risk.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

Vascular & Endovascular

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Bleeding reversal agent pulled from market over FDA’s safety concerns

ACC calls for better management of peripheral artery disease in diabetic patients

Surgeons use modified ‘frozen elephant trunk’ technique for first heart surgery of its kind

New Medtronic thrombectomy system used commercially for first time